Optimal dosage of rituximab for children with Burkitt lymphoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-023-05568-w.pdf
Reference16 articles.
1. Patte C, Philip T, Rodary C, Zucker JM, Gerrard M, Behrendt H et al (1991) High survival rate in advanced stage B-cell lymphomas and leukemias without CNS involvement with a short intensive poly chemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123–132. https://doi.org/10.1200/JCO.1991.9.1.123
2. Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D et al (2001) The Société Française d’Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97:3370–3379. https://doi.org/10.1182/blood.v97.11.3370
3. Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J (2006) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukaemia in children and adolescents. Blood 109:2736–2743. https://doi.org/10.1182/blood-2006-07-036665
4. Minard CV, Auperin A, Pillon M, Burke A, Anderson JR, Donald A et al (2016) Results of the randomized intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): evaluation of Rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen. J Clin Oncol 34:10507. https://doi.org/10.1200/JCO.2016.34.15_suppl.10507
5. Jourdain A, Auperin A, Minard-Colin V, Aladjidi N, Zsiros J, Coze C (2015) Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective “Lymphomes Malins B” protocols. A Societe Francaise des Cancers de l’Enfant study. Haematologica 100:810–817. https://doi.org/10.3324/haematol.2014.121434
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3